Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Buisson

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
Alimentary Pharmacology & Therapeutics|December 28, 2022
Severe colitis in patients with melanoma treated with BRAF/MEK inhibitorsFranck Carbonnel, Emilie Routier, Thierry Lazure, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 20, 2025
Real-world comparison of the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis: the TORUS studyAnthony Buisson, Mélanie Serrero, Romain Altwegg, et al.
Gut Microbes|November 26, 2024
Comparison of Crohn's disease-associated adherent-invasive <i>Escherichia coli</i> (AIEC) from France and Hong Kong: results from the Pacific studyCaroline Chevarin, Zhilu Xu, Lucas Martin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 22, 2024
Development and Validation of a Score to Assess Transmural Healing and Response in Patients With Crohn's DiseaseAnthony Buisson, Jérémy Junda, Jeanne Vignette, et al.
Clinics and Research in Hepatology and Gastroenterology|May 29, 2024
Non-invasive evaluation of mucosal healing by intestinal ultrasound or fecal calprotectin is efficient in Crohn's disease: A cross-sectional studyClara Yzet, Franck Brazier, Vincent Hautefeuille, et al.
Journal of Crohn'S & Colitis|February 7, 2019
Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel DiseasesAnthony Buisson, Wing Yan Mak, Michael J Andersen, et al.
Inflammatory Bowel Diseases|March 6, 2018
IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel DiseasePauline Danion, Anthony Buisson, Xavier Roblin, et al.
Scientific Reports|August 2, 2020
Methyl-donor supplementation prevents intestinal colonization by Adherent-Invasive E. coli in a mouse model of Crohn's diseaseElodie Gimier, Mélissa Chervy, Allison Agus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 31, 2019
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled TrialGilles Bommelaer, David Laharie, Stéphane Nancey, et al.
Gut Microbes|March 26, 2021
Propionate catabolism by CD-associated adherent-invasive <i>E. coli</i> counteracts its anti-inflammatory effectAllison Agus, Damien Richard, Tiphanie Faïs, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Alimentary Pharmacology & Therapeutics|December 28, 2022
Severe colitis in patients with melanoma treated with BRAF/MEK inhibitorsFranck Carbonnel, Emilie Routier, Thierry Lazure, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 20, 2025
Real-world comparison of the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis: the TORUS studyAnthony Buisson, Mélanie Serrero, Romain Altwegg, et al.
Gut Microbes|November 26, 2024
Comparison of Crohn's disease-associated adherent-invasive <i>Escherichia coli</i> (AIEC) from France and Hong Kong: results from the Pacific studyCaroline Chevarin, Zhilu Xu, Lucas Martin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 22, 2024
Development and Validation of a Score to Assess Transmural Healing and Response in Patients With Crohn's DiseaseAnthony Buisson, Jérémy Junda, Jeanne Vignette, et al.
Clinics and Research in Hepatology and Gastroenterology|May 29, 2024
Non-invasive evaluation of mucosal healing by intestinal ultrasound or fecal calprotectin is efficient in Crohn's disease: A cross-sectional studyClara Yzet, Franck Brazier, Vincent Hautefeuille, et al.
Journal of Crohn'S & Colitis|February 7, 2019
Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel DiseasesAnthony Buisson, Wing Yan Mak, Michael J Andersen, et al.
Inflammatory Bowel Diseases|March 6, 2018
IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel DiseasePauline Danion, Anthony Buisson, Xavier Roblin, et al.
Scientific Reports|August 2, 2020
Methyl-donor supplementation prevents intestinal colonization by Adherent-Invasive E. coli in a mouse model of Crohn's diseaseElodie Gimier, Mélissa Chervy, Allison Agus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 31, 2019
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled TrialGilles Bommelaer, David Laharie, Stéphane Nancey, et al.
Gut Microbes|March 26, 2021
Propionate catabolism by CD-associated adherent-invasive <i>E. coli</i> counteracts its anti-inflammatory effectAllison Agus, Damien Richard, Tiphanie Faïs, et al.
Pageof 17